Bioequivalent non-proprietary versions of branded drugs across therapeutic categories. Manufactured by generic drug producers and wholesaled to pharmacies, hospitals, and government health programs. Procured by cost-conscious buyers in public and private healthcare sectors for broad therapeutic applications.